Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 34 of Akebia Therapeutics, Inc.'s SEC filings and found 3 warrant series, 1 ATM program, 1 shelf registration and 1 completed offering on file for AKBA. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 31, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
ADCTADC Therapeutics SA
PYXSPyxis Oncology, Inc.
RNACCartesian Therapeutics, Inc.
DTILPrecision BioSciences, Inc.
ARTVArtiva Biotherapeutics, Inc.
PLXProtalix BioTherapeutics, Inc.
ACIUAC Immune SA
CGENCompugen Ltd
IKTInhibikase Therapeutics, Inc.
ELDNEledon Pharmaceuticals, Inc.
PRQRProQR Therapeutics N.V. Ordinary Shares
PALIPalisade Bio, Inc.
SLGLSol-Gel Technologies Ltd. Ordinary Shares
BBOTBridgeBio Oncology Therapeutics Inc.
TRDAEntrada Therapeutics, Inc.